eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa for a Male patient aged 58

This is a personalized study for a 58 year old male patient. The study is created by eHealthMe based on reports of 19 people who take the same drugs and have drug interactionsfrom FDA.

On Oct, 30, 2014: 19 people who reported to have interactions when taking Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa are studied

Trend of Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa's drug interactions, side effects, and effectiveness reports (3352906)

Information of the patient in this study:

Age: 58

Gender: male

Conditions: Hallucination, Parkinson's Disease

Drugs taking:
- Quetiapine Fumarate
- Cabergoline
- Carbidopa And Levodopa

Drug interactions have: Ventricular Tachycardia, Temperature Regulation Disorder, Stupor, Psychiatric Symptom, Muscle Rigidity, Hypothermia, Hypothalamo-pituitary Disorder, Heart Rate Decreased, Depressed Level Of Consciousness, Cognitive Disorder, Cardio-respiratory Arrest, Brain Stem Syndrome, Akinesia

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 58 (±5):

InteractionNumber of reports
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)4 (33.33%)
Temperature Regulation Disorder (body is unable to maintain temperature)2 (16.67%)
Stupor (lack of critical cognitive function and level of consciousness)2 (16.67%)
Psychiatric Symptom6 (50.00%)
Muscle Rigidity (muscle stiffness)2 (16.67%)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)4 (33.33%)
Hypothalamo-pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function)2 (16.67%)
Heart Rate Decreased2 (16.67%)
Depressed Level Of Consciousness2 (16.67%)
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving)2 (16.67%)
Cardio-respiratory Arrest (sudden dysfunction of heart and lungs)4 (33.33%)
Brain Stem Syndrome2 (16.67%)
Akinesia (loss of control of voluntary muscle movements)2 (16.67%)

Most common interactions experienced by males aged 58 (±5) in the use of Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa:

InteractionNumber of reports
Dopamine Dysregulation Syndrome (complication of the dopaminergic treatment in parkinson's disease)6
Psychiatric Symptom6
Intentional Overdose6
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)6
Dyspnoea (difficult or laboured respiration)4
Bone Disorder4
Bundle Branch Block Left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)4
Depression4
Drug Abuse4
Cerebrovascular Accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)4

Most common interactions experienced by males aged 58 (±5) in long term use of Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa:

None.

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart)4 (21.05%)
Temperature Regulation Disorder (body is unable to maintain temperature)2 (10.53%)
Stupor (lack of critical cognitive function and level of consciousness)2 (10.53%)
Psychiatric Symptom6 (31.58%)
Muscle Rigidity (muscle stiffness)2 (10.53%)
Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)4 (21.05%)
Hypothalamo-pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function)2 (10.53%)
Heart Rate Decreased2 (10.53%)
Depressed Level Of Consciousness2 (10.53%)
Cognitive Disorder (mental health disorders affects learning, memory, perception, and problem solving)2 (10.53%)
Cardio-respiratory Arrest (sudden dysfunction of heart and lungs)4 (21.05%)
Brain Stem Syndrome2 (10.53%)
Akinesia (loss of control of voluntary muscle movements)2 (10.53%)

Most common interactions experienced by people in the use of Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa:

InteractionNumber of reports
Pathological Gambling8
Impulsive Behaviour8
Fall8
Subdural Haematoma (blood collects between the skull and the surface of the brain)8
Psychiatric Symptom6
Intentional Overdose6
Retinal Detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)6
Dopamine Dysregulation Syndrome (complication of the dopaminergic treatment in parkinson's disease)6
Persecutory Delusion6
Hallucination, Visual (seeing things that aren't there)6

Most common interactions experienced by people in long term use of Quetiapine Fumarate, Cabergoline, Carbidopa And Levodopa:

None.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.